BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1824985)

  • 1. Gangliosides potentiate cyclosporine A-induced suppression of allospecific immune responses.
    Spagnoli GC; Ausiello CM; Sconocchia G; Adorno D; Casciani CU
    Transplant Proc; 1991 Feb; 23(1 Pt 1):342-5. PubMed ID: 1824985
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporin A inhibits IL 2-driven proliferation of human alloactivated T cells.
    Buurman WA; Ruers TJ; Daemen IA; van der Linden CJ; Groenewegen G
    J Immunol; 1986 Jun; 136(11):4035-9. PubMed ID: 2939138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2.
    Bunjes D; Hardt C; Röllinghoff M; Wagner H
    Eur J Immunol; 1981 Aug; 11(8):657-61. PubMed ID: 6456149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro immunosuppressive effect of deoxymethylspergualin.
    Jiang H; Takahara S; Takano Y; Machida M; Iwasaki A; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Sonoda T
    Transplant Proc; 1990 Aug; 22(4):1633-7. PubMed ID: 2143857
    [No Abstract]   [Full Text] [Related]  

  • 5. Synergistic effect of the rapamycin-cyclosporine combination: median effect analysis of in vitro immune performances by human T lymphocytes in PHA, CD3, and MLR proliferative and cytotoxicity assays.
    Kahan BD; Gibbons S; Tejpal N; Chou TC; Stepkowski S
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1090-1. PubMed ID: 1824888
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine blocks the activation of antigen-dependent cytotoxic T lymphocytes directly by an IL-2-independent mechanism.
    Havele C; Paetkau V
    J Immunol; 1988 May; 140(10):3303-8. PubMed ID: 2966195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor promoters in conjunction with calcium ionophores mimic antigenic stimulation by reactivation of alloantigen-primed murine T lymphocytes.
    Isakov N; Altman A
    J Immunol; 1985 Dec; 135(6):3674-80. PubMed ID: 2999231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine-induced tolerance in experimental organ transplantation. Evidence of diminished donor-specific cytotoxicity relative to donor-specific proliferative response.
    Norin AJ; Kamholz SL; Pinsker KL; Emeson EE; Veith FJ
    J Immunol; 1987 Jul; 139(2):332-7. PubMed ID: 2955037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive effects of cyclosporin A on cloned T cells.
    Herold KC; Lancki DW; Moldwin RL; Fitch FW
    J Immunol; 1986 Feb; 136(4):1315-21. PubMed ID: 2935576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunobiology of experimental lung transplantation with cyclosporine immunosuppression: cytolytic T lymphocytes and delayed type hypersensitivity in rejecting and tolerant recipients.
    Norin AJ
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):125-30. PubMed ID: 2966476
    [No Abstract]   [Full Text] [Related]  

  • 11. A new immunosuppressive agent, FK506, inhibits the expression of alloantigen-activated suppressor cells as well as the induction of alloreactivity.
    Yoshimura N; Matsui S; Hamashima T; Lee CJ; Oka T
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1045-7. PubMed ID: 2468202
    [No Abstract]   [Full Text] [Related]  

  • 12. The differential inhibitory effects exerted by cyclosporine and hydrocortisone on the activation of human cytotoxic lymphocytes by recombinant interleukin-2 versus allospecific CTL.
    Grimm EA; Muul LM; Wilson DJ
    Transplantation; 1985 May; 39(5):537-40. PubMed ID: 3158107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4 bypasses the immune suppressive effect of cyclosporin A during the in vitro induction of murine cytotoxic T lymphocytes.
    Heeg K; Gillis S; Wagner H
    J Immunol; 1988 Oct; 141(7):2330-4. PubMed ID: 3262657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of cloned T cell function. I. Dissection of cloned T cell proliferative responses using cyclosporin A.
    Orosz CG; Fidelus RK; Roopenian DC; Widmer MB; Ferguson RM; Bach FH
    J Immunol; 1982 Nov; 129(5):1865-8. PubMed ID: 6214580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive properties of enisoprost and a 5-lipoxygenase inhibitor (SC 45662).
    Weir MR; Li XW; Gomolka D; Peppler R; O'Bryan-Tear G; Moran M
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1074-7. PubMed ID: 1989152
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF.
    Hess AD; Tutschka PJ; Santos GW
    J Immunol; 1982 Jan; 128(1):355-9. PubMed ID: 6459374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive activity of cyclosporine metabolites in vitro.
    Schlitt HJ; Christians U; Wonigeit K; Sewing KF; Pichlmayr R
    Transplant Proc; 1987 Oct; 19(5):4248-51. PubMed ID: 2960052
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of FK 506 on in vivo immunity in comparison to cyclosporine.
    Takaori K; Nio Y; Inoue K; Aung T; Tun T; Hashida T; Yasuhara M; Hori R; Tobe T
    Transplant Proc; 1991 Dec; 23(6):2948-9. PubMed ID: 1721322
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporin. Mechanism of action: in vitro studies.
    Hess AD; Colombani PM
    Prog Allergy; 1986; 38():198-221. PubMed ID: 2941763
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of 15-deoxyspergualin on the induction of cytotoxic T lymphocytes and bone marrow suppression.
    Nishimura K; Tokunaga T
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1104-7. PubMed ID: 2784883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.